{{Drugbox
| IUPAC_name = 2-[4-(Diphenylmethyl)piperazin-1-yl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
| image = Manidipine.svg
| width = 250px

<!--Clinical data-->
| tradename = Manyper, etc.
| Drugs.com = {{drugs.com|international|manidipine}}
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 89226-50-6
| CAS_supplemental = {{CAS|120092-68-4}}
| ATC_prefix = C08
| ATC_suffix = CA11
| PubChem = 4008
| DrugBank =  
| ChemSpiderID = 3868
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6O4754US88

<!--Chemical data-->
| C=35 | H=38 | N=4 | O=6 
| molecular_weight = 610.69 g/mol
| smiles = [O-][N+](=O)c1cccc(c1)C5C(/C(=O)OC)=C(\N\C(=C5\C(=O)OCCN4CCN(C(c2ccccc2)c3ccccc3)CC4)C)C
| StdInChI = 1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16,23,32-33,36H,17-22H2,1-3H3
}}

'''Manidipine''' ([[International Nonproprietary Name|INN]]) is a [[calcium channel blocker]] (dihydropyridine type) that is used clinically as an [[antihypertensive]].<ref>{{Citation
 | title = Manidipine: A Review of its Use in Hypertension
 | url = http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200161120-00010.htm
 | year = 2001
 | journal = Drugs
 | pages = 1777–99
 | volume = 61
 | issue = 12
 | last1 = Cheer	 | first1 =  S.M.
 | last2 =  McClellan	 | first2 =  K.
 | accessdate = 2009-06-20
 | pmid = 11693466	
 | doi=10.2165/00003495-200161120-00010}}</ref><ref>{{Citation
 | title = Manidipine: A Review of its Use in the Management of Hypertension
 | url = http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200464170-00011.htm
 | year = 2004
 | journal = Drugs
 | pages = 1923–40
 | volume = 64
 | issue = 17
 | last1 = McKeage	 | first1 =  K.
 | last2 =  Scott	 | first2 =  L.J.
 | accessdate = 2009-06-20
 | pmid = 15329044	
 | doi=10.2165/00003495-200464170-00011}}</ref><ref>{{Citation
 | title = Antihypertensive Effect of Manidipine
 | url = http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200565002-00003.htm
 | year = 2005
 | journal = Drugs
 | pages = 11–9
 | volume = 65
 | last1 = Roca-cusachs	 | first1 =  A.
 | last2 =  Triposkiadis	 | first2 =  F.
 | accessdate = 2009-06-20
 | pmid = 16398058	
 | doi=10.2165/00003495-200565002-00003}}</ref><ref name=Otero2007>{{Citation
 | title = Manidipine–delapril combination in the management of hypertension
 | year = 2007
 | author = Otero, M.L.
 | journal = Vascular Health and Risk Management
 | pages = 255–63
 | volume = 3
 | issue = 3
 | pmid = 17703633
 | pmc = 2293964
}}</ref><ref>{{Citation
| doi = 10.1016/S0011-393X(05)80475-8
| volume = 52
| issue = 2
| pages = 248–253
| last1 = Mizuno | first1 = Kenji
| last2 = Haga | first2 = Hiroshi
| last3 = Takahashi | first3 = Michihiko
| last4 = Fukuchi | first4 = Soitsu
| title = Evaluation of manidipine hydrochloride, a new calcium antagonist, in the treatment of hypertensive patients with renal disorders
| journal = Current Therapeutic Research
| accessdate = 2009-06-20
| date = August 1992
| url = http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VS8-4GHBHXV-5&_user=10&_coverDate=08%2F31%2F1992&_rdoc=5&_fmt=high&_orig=browse&_srch=doc-info(%23toc%236256%231992%23999479997%23600363%23FLP%23display%23Volume)&_cdi=6256&_sort=d&_docanchor=&_ct=16&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=4a139e549c7d88da59d7ebdfe6f44be7
}}</ref>

==References==
{{Reflist}}

{{Calcium channel blockers}}
{{Piperazines}}

[[Category:Calcium channel blockers]]
[[Category:Piperazines]]
[[Category:Dihydropyridines]]
[[Category:Nitrobenzenes]]
[[Category:Carboxylate esters]]


{{Cardiovascular-drug-stub}}